Laurion Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-196,886
| Closed | -$4.99M | – | 482 |
|
|
2025
Q1 | $4.99M | Buy |
+196,886
| New | +$5.15M | 0.13% | 109 |
|
|
2024
Q3 | – | Sell |
-35,470
| Closed | -$992K | – | 527 |
|
|
2024
Q2 | $992K | Sell |
35,470
-864,530
| -96% | -$23.8M | 0.01% | 293 |
|
|
2024
Q1 | $25M | Sell |
900,000
-1,545,346
| -63% | -$42.9M | 0.21% | 98 |
|
|
2023
Q4 | $70.4M | Buy |
2,445,346
+1,408,823
| +136% | +$42.6M | 0.6% | 45 |
|
|
2023
Q3 | $34.4M | Buy |
1,036,523
+617,355
| +147% | +$21.8M | 0.21% | 97 |
|
|
2023
Q2 | $15.4M | Buy |
419,168
+342,984
| +450% | +$13.3M | 0.09% | 182 |
|
|
2023
Q1 | $3.11M | Buy |
76,184
+11,542
| +18% | +$499K | 0.02% | 258 |
|
|
2022
Q4 | $3.31M | Buy |
+64,642
| New | +$3.1M | 0.02% | 286 |
|
|
2022
Q3 | – | Sell |
-14,557
| Closed | -$763K | – | 584 |
|
|
2022
Q2 | $763K | Buy |
14,557
+10,357
| +247% | +$528K | 0.01% | 307 |
|
|
2022
Q1 | $217K | Buy |
+4,200
| New | +$218K | ﹤0.01% | 470 |
|
|
2021
Q3 | – | Sell |
-101,353
| Closed | -$3.97M | – | 829 |
|
|
2021
Q2 | $3.97M | Buy |
101,353
+54,206
| +115% | +$2.11M | 0.02% | 301 |
|
|
2021
Q1 | $1.71M | Buy |
47,147
+32,514
| +222% | +$1.15M | 0.01% | 443 |
|
|
2020
Q4 | $539K | Sell |
14,633
-249,234
| -94% | -$9.14M | ﹤0.01% | 476 |
|
|
2020
Q3 | $9.19M | Sell |
263,867
-181,716
| -41% | -$6.37M | 0.11% | 171 |
|
|
2020
Q2 | $13.8M | Buy |
+445,583
| New | +$15.1M | 0.16% | 153 |
|
|
2019
Q4 | – | Sell |
-105
| Closed | -$3.74K | – | 1148 |
|
|
2019
Q3 | $4K | Buy |
+105
| New | +$3.82K | ﹤0.01% | 977 |
|
|
2019
Q1 | – | Sell |
-23,854
| Closed | -$988K | – | 1197 |
|
|
2018
Q4 | $988K | Buy |
23,854
+19,718
| +477% | +$819K | 0.02% | 560 |
|
|
2018
Q3 | $173K | Sell |
4,136
-127,912
| -97% | -$4.92M | ﹤0.01% | 1061 |
|
|
2018
Q2 | $4.54M | Sell |
132,048
-69,805
| -35% | -$2.39M | 0.04% | 373 |
|
|
2018
Q1 | $6.8M | Sell |
201,853
-62,069
| -24% | -$2.13M | 0.05% | 301 |
|
|
2017
Q4 | $9.07M | Buy |
263,922
+83,705
| +46% | +$2.85M | 0.05% | 371 |
|
|
2017
Q3 | $6.1M | Sell |
180,217
-169,804
| -49% | -$5.46M | 0.03% | 446 |
|
|
2017
Q2 | $11.2M | Sell |
350,021
-21,600
| -6% | -$681K | 0.06% | 293 |
|
|
2017
Q1 | $12.1M | Buy |
371,621
+173,969
| +88% | +$5.49M | 0.09% | 237 |
|
|
2016
Q4 | $6.09M | Buy |
197,652
+189,220
| +2,244% | +$5.78M | 0.06% | 311 |
|
|
2016
Q3 | $271K | Buy |
+8,432
| New | +$282K | ﹤0.01% | 740 |
|
|
2016
Q1 | – | Sell |
-537,888
| Closed | -$15.4M | – | 1021 |
|
|
2015
Q4 | $16.5M | Buy |
537,888
+142,315
| +36% | +$4.48M | 0.15% | 142 |
|
|
2015
Q3 | $11.8M | Sell |
395,573
-437,401
| -53% | -$14M | 0.14% | 142 |
|
|
2015
Q2 | $26.5M | Buy |
+832,974
| New | +$27.1M | 0.24% | 115 |
|
|
2014
Q4 | – | Sell |
-557,097
| Closed | -$16M | – | 403 |
|
|
2014
Q3 | $15.6M | Buy |
557,097
+536,860
| +2,653% | +$15.1M | 0.33% | 85 |
|
|
2014
Q2 | $570K | Buy |
+20,237
| New | +$577K | 0.01% | 223 |
|
|
2013
Q3 | – | Sell |
-62,572
| Closed | -$1.66M | – | 210 |
|
|
2013
Q2 | $1.66M | Buy |
+62,572
| New | +$1.73M | 0.1% | 117 |
|
Other funds holding PFE
Laurion Capital Management's PFE Position: Q2 2025 in Review
Laurion Capital Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 196,886 shares — an estimated $4.99M sold.
Laurion Capital Management first reported a position in PFE in Q2 2013 and held it in 32 quarters. The position peaked at $70.4M in Q4 2023. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Laurion Capital Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Laurion Capital Management sold 196,886 Pfizer shares in Q2 2025, an estimated $4.99M.
- Laurion Capital Management first reported a position in Pfizer in Q2 2013 and held it in 32 quarters.
- Laurion Capital Management's Pfizer position peaked at $70.4M in Q4 2023.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Laurion Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.